Major shareholder announcement

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.

Per September 3, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,415,760 shares, corresponding to 5.00% (previously 4.99%) of the total share capital attached to shares. The combined total of share capital attached to shares and share capital through financial instruments is 5.01%.

Attachments

• Novozymes B 3 Sept 2024 Final
• 2024_33_Major_Shareholders_Announcement

You May Also Be Interested In

• Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
• Wilder Intelligence Inc. Launches Wilder AI: The High-Stakes Research Platform Where Accuracy Is the Baseline, Not the Upgrade
• Global EV Transition Continues to Drive Interest as ELEKTROS Advances Its Vision for Lithium, Critical Minerals and Charging Innovation